NO992676L - 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse - Google Patents

1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse

Info

Publication number
NO992676L
NO992676L NO992676A NO992676A NO992676L NO 992676 L NO992676 L NO 992676L NO 992676 A NO992676 A NO 992676A NO 992676 A NO992676 A NO 992676A NO 992676 L NO992676 L NO 992676L
Authority
NO
Norway
Prior art keywords
diazabicyclo
oct
preparation
therapeutic use
ylmethyl
Prior art date
Application number
NO992676A
Other languages
English (en)
Other versions
NO992676D0 (no
Inventor
Alistair Lochead
Samir Jegham
Alain Nedelec
Axelle Solignac
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO992676D0 publication Critical patent/NO992676D0/no
Publication of NO992676L publication Critical patent/NO992676L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Oppfinnelsen vedrører forbindelser med generell formel (I) hvor RI representerer en metylgruppe, Xx representerer et hydrogenatom eller ORX og Xx danner sammen en gruppe med formel -O(CH2)2-, -O(CH2)3-, -O(CH2)20- eller -O(CH2)3O-, X2 representerer et hydrogenatom eller en aminogruppe og X3 representerer et halogenatom. Forbindelsene er ligander av serotoninergiske reseptorer av typene 5-HT3 og/eller '5-HT4, og virker som 5-HT4 agonister og/eller 5-HT3 antagonister.
NO992676A 1996-12-04 1999-06-02 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse NO992676L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614847A FR2756563B1 (fr) 1996-12-04 1996-12-04 Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique
PCT/FR1997/002174 WO1998024790A1 (fr) 1996-12-04 1997-12-02 Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-ylmethyle, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
NO992676D0 NO992676D0 (no) 1999-06-02
NO992676L true NO992676L (no) 1999-07-29

Family

ID=9498306

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992676A NO992676L (no) 1996-12-04 1999-06-02 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse

Country Status (19)

Country Link
US (1) US6057321A (no)
EP (1) EP0942910A1 (no)
JP (1) JP2001504855A (no)
KR (1) KR20000069283A (no)
CN (1) CN1239962A (no)
AU (1) AU7624598A (no)
BG (1) BG103432A (no)
BR (1) BR9714215A (no)
CA (1) CA2271072A1 (no)
CZ (1) CZ193799A3 (no)
EE (1) EE9900218A (no)
FR (1) FR2756563B1 (no)
HU (1) HUP9904206A3 (no)
IL (1) IL129927A0 (no)
NO (1) NO992676L (no)
NZ (1) NZ336044A (no)
SK (1) SK74199A3 (no)
TR (1) TR199901068T2 (no)
WO (1) WO1998024790A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11506744A (ja) 1995-06-07 1999-06-15 ノウブン ファーマシューティカルズ インク. 室温で液体である低分子量薬を含む経皮組成物
CA2520066A1 (en) * 2003-04-08 2004-10-21 Ciba Specialty Chemicals Holding Inc. Light stabilising polymer dispersants in pigment dispersions
US7880683B2 (en) * 2004-08-18 2011-02-01 Ruckus Wireless, Inc. Antennas with polarization diversity
JP5278312B2 (ja) 2007-04-16 2013-09-04 ダイキン工業株式会社 含フッ素エラストマー組成物およびそれからなるシール材
CN101842375A (zh) * 2007-09-03 2010-09-22 巴斯夫欧洲公司 制备teda衍生物的方法
US20110077376A1 (en) * 2008-05-30 2011-03-31 Katsumi Tokumoto Process for producing hydroxyalkyltriethylenediamine, and catalyst composition for the production of polyurethane resin using it
EP2295438B2 (en) * 2008-05-30 2025-03-26 Tosoh Corporation Process for producing hydroxyalkyltriethylenediamine compound, and catalyst composition for the production of polyurethane resin using the hydroxyalkyltriethylenediamine compound
CN101671336B (zh) * 2009-09-23 2013-11-13 辽宁利锋科技开发有限公司 芳杂环并嘧啶衍生物和类似物及其制备方法和用途
JP5504835B2 (ja) * 2009-11-13 2014-05-28 東ソー株式会社 ヒドロキシアルキルピペラジン類及び/又はヒドロキシメチルトリエチレンジアミン類の製造方法
JP5549847B2 (ja) * 2009-11-16 2014-07-16 東ソー株式会社 N−(2−アルコキシメチル)トリエチレンジアミン類の製造法
JP5707912B2 (ja) * 2010-12-08 2015-04-30 東ソー株式会社 N−(ジヒドロキシアルキル)ジエチレントリアミン類の組成物、及びそれを用いた2−ヒドロキシ(アルキル)トリエチレンジアミン類の製造方
JP6393959B2 (ja) 2012-05-31 2018-09-26 東ソー株式会社 ポリウレタン樹脂製造用触媒組成物及びそれを用いたポリウレタン樹脂の製造方法
JP6252152B2 (ja) * 2013-12-11 2017-12-27 東ソー株式会社 二環式アミン化合物の製造方法
KR20220055152A (ko) 2020-10-26 2022-05-03 인하대학교 산학협력단 급성 융모양막염 진단용 조성물 및 이를 이용한 급성 융모양막염 진단방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
TW282460B (no) * 1993-12-28 1996-08-01 Yamanouchi Pharma Co Ltd
FR2735475B1 (fr) * 1995-06-13 1997-07-11 Synthelabo Derives de n-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl) benzamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
CZ193799A3 (cs) 1999-09-15
AU7624598A (en) 1998-06-29
HUP9904206A2 (hu) 2000-06-28
FR2756563A1 (fr) 1998-06-05
US6057321A (en) 2000-05-02
CA2271072A1 (fr) 1998-06-11
JP2001504855A (ja) 2001-04-10
NO992676D0 (no) 1999-06-02
FR2756563B1 (fr) 1998-12-24
CN1239962A (zh) 1999-12-29
HUP9904206A3 (en) 2000-07-28
IL129927A0 (en) 2000-02-29
KR20000069283A (ko) 2000-11-25
BR9714215A (pt) 2000-04-18
WO1998024790A1 (fr) 1998-06-11
TR199901068T2 (xx) 1999-07-21
NZ336044A (en) 2000-03-27
BG103432A (en) 2000-06-30
SK74199A3 (en) 2000-02-14
EP0942910A1 (fr) 1999-09-22
EE9900218A (et) 1999-12-15

Similar Documents

Publication Publication Date Title
NO992676L (no) 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
ATE139233T1 (de) Annelierte thiophen-derivate, ihre herstellung und verwendung
DK0870768T3 (da) Azaindol-ethylaminderivater som nikotinacetylcholinreceptor-bindingsmidler
NO960365L (no) Perhydroisoindolderivater som substans-P-antagonister
PE20020506A1 (es) Derivados de pirazol fusionados como inhibidores de la proteina cinasa
BR0111538A (pt) Derivados de 1,3,8-triaza-espiro 4,5!decan-4-ona como antogonistas de receptor de neurocinina
TR200101155T2 (tr) 4-Aroil Piperidin CCR-3 Reseptör Antagonistleri III
YU157191A (sh) Antagonisti receptora fibrinogena
DK0958296T3 (da) Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme
ATE235476T1 (de) Thiazolidindione derivate, ihre herstellung und verwendung
ES2174298T3 (es) Derivados de aminotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE69017593D1 (de) Substituierte N-(Imidazolyl)alkyl-alanin-Derivate.
NO20050666L (no) 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
HUP9700595A1 (hu) Fluor-alkil- és fluor-alkoxicsoporttal helyettesített heterociklikus bradikinin-antagonisták, eljárás ezek előállítására, valamint ezek alkalmazása
EA200200729A1 (ru) Производные 4-фенил-1-пиперазинила, -пиперидинила и -тетрагидропиридила
MXPA03010321A (es) Derivados de 1-oxa-3,9-diaza-spiro-5,5-undecan-2-onas y su uso como antagonista del receptor de neurocinina.
AP9801410A0 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists.
HUP0003962A2 (hu) Kinuklidinil-származékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények, e vegyületek alkalmazása, valamint intermedierjeik
DE69510510D1 (de) N-benzoylmethylsubstituierte paroxetinderivate
DK1347960T3 (da) Fremgangsmåde til fremstilling af (+/-) trans-4-p-fluorphenyl-3-hydromethyl-1-methylpiperidin
DE69402703D1 (de) 3-(INDOL-3-YL) PROPENSäURDERIVATE, DIE ALS NMDA- ANTAGONISTEN NÜTZLICH SIND
HUP0104045A2 (hu) Eljárás 4-[(2',5'-diamino-6'-halogén-pirimidin-4'-il)-amino]-ciklopent-2-enilmetanol-származékok előállítására
DK0765322T3 (da) Indolderivater som pro-drugs for 5-HT1-lignende receptoragonister
DE69501810D1 (de) Verwendung von 5-Thia-1,4-Diazabicyclo [4.2.0] Octane-3,8-dioxo Verbindungen in der Antitumor-Therapie
ES2127699A1 (es) Nuevos derivados de 2,3-benzodiazepina.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application